Prognostic Potential of Galectin-9 mRNA Expression in Chronic Lymphocytic Leukemia

Prognostic Potential of Galectin-9 mRNA Expression in Chronic Lymphocytic Leukemia

Galectin-9 (Gal-9), very poorly characterized in chronic lymphocytic leukemia (CLL), was chosen in our study to examine its potential role as a CLL biomarker. The relation of Gal-9 expression in malignant B-cells and other routinely measured CLL markers, as well as its clinical relevance are poorly...

Full description

Bibliographic Details
Main Authors:	Agnieszka Bojarska-Junak, Wioleta Kowalska, Sylwia Chocholska, Agata Szymańska, Waldemar Tomczak, Michał Konrad Zarobkiewicz, Jacek Roliński
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	Cancers
Subjects:	CLL Galectin-9 EBV prognostic markers biomarker
Online Access:	https://www.mdpi.com/2072-6694/15/22/5370

Similar Items

Can Galectin-3 Be a Novel Biomarker in Chronic Lymphocytic Leukemia?
by: Justyna Woś, et al.
Published: (2023-12-01)

Prognostic Value of the miR-17~92 Cluster in Chronic Lymphocytic Leukemia
by: Sylwia Chocholska, et al.
Published: (2023-01-01)

Prognostic Value of Tie2-Expressing Monocytes in Chronic Lymphocytic Leukemia Patients
by: Justyna Woś, et al.
Published: (2021-06-01)

The Mysterious Actor—γδ T Lymphocytes in Chronic Lymphocytic Leukaemia (CLL)
by: Michał K. Zarobkiewicz, et al.
Published: (2022-02-01)

High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients
by: Anna Trebo, et al.
Published: (2020-04-01)

Chronic active Epstein-Barr virus infection as the basis of neoplasm development. Transformation of chronic lymphocytic leukaemia to NK-cell lymphoma/leukaemia was observed by flow cytometry – a diagnostic report
by: Katarzyna Karwicka, et al.
Published: (2023-09-01)

Role of Galectins in Multiple Myeloma
by: Paola Storti, et al.
Published: (2017-12-01)

Association of Common Variants of <i>TNFSF13</i> and <i>TNFRSF13B</i> Genes with CLL Risk and Clinical Picture, as Well as Expression of Their Products—APRIL and TACI Molecules
by: Monika Jasek, et al.
Published: (2020-10-01)

The role of interleukin 22 in multiple sclerosis and its association with c-Maf and AHR
by: Michal Konrad Zarobkiewicz, et al.
Published: (2019-09-01)

Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?
by: Yuanwei Shi, et al.
Published: (2022-05-01)

Regulation of S100As Expression by Inflammatory Cytokines in Chronic Lymphocytic Leukemia
by: Olivera Mitrović Ajtić, et al.
Published: (2022-06-01)

Atypical Chronic Lymphocytic Leukemia—The Current Status
by: Tadeusz Robak, et al.
Published: (2023-09-01)

Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials
by: Daniel Compagno, et al.
Published: (2020-05-01)

Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells
by: Jing-xiao Xu, et al.
Published: (2023-02-01)

Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
by: Fei Kong, et al.
Published: (2020-09-01)

Could Galectin 3 Be a Good Prognostic Factor in Endometrial Cancer?
by: Aneta Cymbaluk-Płoska, et al.
Published: (2020-08-01)

The role of salivary galectin-3 and galectin-9 levels in plaque-induced gingivitis and periodontitis
by: Zerrin Barut, et al.
Published: (2023-09-01)

An Updated Perspective on Current Prognostic and Predictive Biomarkers in Chronic Lymphocytic Leukemia in the Context of Chemoimmunotherapy and Novel Targeted Therapy
by: Jared A. Cohen, et al.
Published: (2020-04-01)

Reduced Percentage of CD14<sup>dim</sup>CD16<sup>+</sup>SLAN<sup>+</sup> Monocytes Producing TNF and IL-12 as an Immunological Sign of CLL Progression
by: Wioleta Kowalska, et al.
Published: (2022-03-01)

Galectins as Cancer Biomarkers
by: Vitaly Balan, et al.
Published: (2010-04-01)

Galectin 3: an extraordinary multifunctional protein in dermatology. Current knowledge and perspectives
by: Efstathia Pasmatzi, et al.
Published: (2019-07-01)

Galectin-1 and Galectin-3 in B-Cell Precursor Acute Lymphoblastic Leukemia
by: Fei Fei, et al.
Published: (2022-11-01)

A unique maternal and placental galectin signature upon SARS-CoV-2 infection suggests galectin-1 as a key alarmin at the maternal–fetal interface
by: Fangqi Zhao, et al.
Published: (2023-07-01)

Pattern Analysis of Serum Galectins-1, -3, and -9 in Breast Cancer
by: Avery Funkhouser, et al.
Published: (2023-07-01)

The Role of Neutrophils in the Pathogenesis of Chronic Lymphocytic Leukemia
by: Malgorzata Wachowska, et al.
Published: (2021-12-01)

Therapeutic Management of Chronic Lymphocytic Leukemia Presenting with Recurrent Massive Ascites
by: Ugochi Ebinama, et al.
Published: (2022-09-01)

Molecular-genetic markers: prognostic factors in B-cell chronic lymphocytic leukemia
by: A. I. Zakharova, et al.
Published: (2022-11-01)

Significance of the Galectin-8 Immunohistochemical Profile in Ovarian Cancer
by: Elena-Roxana Avădănei, et al.
Published: (2024-01-01)

Galectin-3: A Potential Prognostic and Diagnostic Marker for Heart Disease and Detection of Early Stage Pathology
by: Akira Hara, et al.
Published: (2020-09-01)

Clinical Relevance of Galectin-1 and Galectin-3 in Rheumatoid Arthritis Patients: Differential Regulation and Correlation With Disease Activity
by: Santiago P. Mendez-Huergo, et al.
Published: (2019-01-01)

Galectin‐9 and myeloid‐derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia
by: Xierenguli Alimu, et al.
Published: (2023-05-01)

BTLA Expression in CLL: Epigenetic Regulation and Impact on CLL B Cell Proliferation and Ability to IL-4 Production
by: Lidia Karabon, et al.
Published: (2021-11-01)

Exploring the Molecular Interactions of Symmetrical and Unsymmetrical Selenoglycosides with Human Galectin-1 and Galectin-3
by: Luciano Pirone, et al.
Published: (2022-07-01)

Serum Galectin‐1, Galectin‐9, and YKL‐40 levels in bipolar disorder and their relationship with cognitive functions
by: Elcicek Selahaddin, et al.
Published: (2024-02-01)

Panel Sequencing for Clinically Oriented Variant Screening and Copy Number Detection in Chronic Lymphocytic Leukemia Patients
by: Mariam Ibáñez, et al.
Published: (2022-04-01)

Galectins in Equine Placental Disease
by: Carleigh E. Fedorka, et al.
Published: (2023-03-01)

Challenges in Diagnosis and Clinical Management of COVID-19 in Patient with B-Cell Chronic Lymphocytic Leukemia (CLL): Report of One Case
by: Vincenzo Visco, et al.
Published: (2022-03-01)

Super-Enhancer–Associated nine-gene prognostic score model for prediction of survival in chronic lymphocytic leukemia patients
by: Xue Liang, et al.
Published: (2022-09-01)

PECAM-1 Is Down-Regulated in γδT Cells during Remission, but Up-Regulated in Relapse of Multiple Sclerosis
by: Michał K. Zarobkiewicz, et al.
Published: (2022-06-01)

Prognostication of DNA Damage Response Protein Expression Patterns in Chronic Lymphocytic Leukemia
by: Ti’ara L. Griffen, et al.
Published: (2023-03-01)